Literature DB >> 8360211

New ideas in biomaterials science--a path to engineered biomaterials.

B D Ratner1.   

Abstract

Our existing biomaterials, although demonstrating generally satisfactory clinical performance, were developed based upon a trial-and-error optimization approach rather than being engineered to produce the desired interfacial reaction. Most biomaterials exhibit a nonspecific biological reaction, with sluggish kinetics and a broad spectrum of active processes simultaneously occurring. This article describes materials science nanotechnology, and molecular biology techniques that may permit the synthesis of precisely engineered surfaces. Such surfaces might demonstrate rapid, precise reactions with proteins and cells. This opens the question, "what type of specific surface bioreactions do we want?" New thoughts on biocompatibility are presented that may be helpful in the design of specific surfaces yielding precise, defined biological responses.

Mesh:

Substances:

Year:  1993        PMID: 8360211     DOI: 10.1002/jbm.820270702

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  35 in total

1.  Probing the orientation of electrostatically immobilized Protein G B1 by time-of-flight secondary ion spectrometry, sum frequency generation, and near-edge X-ray adsorption fine structure spectroscopy.

Authors:  Joe E Baio; Tobias Weidner; Loren Baugh; Lara J Gamble; Patrick S Stayton; David G Castner
Journal:  Langmuir       Date:  2011-12-22       Impact factor: 3.882

2.  Structure of the interface between rabbit cortical bone and implants of gold, zirconium and titanium.

Authors:  P Thomsen; C Larsson; L E Ericson; L Sennerby; J Lausmaa; B Kasemo
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

3.  Morphological and chemical characterization of microfabricated fibres for biological applications.

Authors:  J Gold; B Kasemo
Journal:  J Mater Sci Mater Med       Date:  1997-05       Impact factor: 3.896

4.  Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity.

Authors:  T R Kyriakides; K J Leach; A S Hoffman; B D Ratner; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  [Peri-implant bone formation around cylindrical and conical implant systems].

Authors:  A Büchter; J Kleinheinz; H-P Wiesmann; L Seper; U Joos; U Meyer
Journal:  Mund Kiefer Gesichtschir       Date:  2004-07-23

6.  Protein-imprinted polysiloxane scaffolds.

Authors:  K Lee; R R Itharaju; D A Puleo
Journal:  Acta Biomater       Date:  2007-03-23       Impact factor: 8.947

7.  The surface modification of stainless steel and the correlation between the surface properties and protein adsorption.

Authors:  Chan-Koo Kang; Yoon-Sik Lee
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

8.  Long-term evaluation of corneal endothelial cell transplantation.

Authors:  J Mohay; T O Wood; B J McLaughlin
Journal:  Trans Am Ophthalmol Soc       Date:  1997

9.  The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation.

Authors:  Themis R Kyriakides; Matt J Foster; Grant E Keeney; Annabel Tsai; Cecilia M Giachelli; Ian Clark-Lewis; Barrett J Rollins; Paul Bornstein
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  ZrO(2)/hydroxyapatite coating on titanium by electrolytic deposition.

Authors:  Hsueh-Chuan Hsu; Shih-Ching Wu; Chih-Hsiung Yang; Wen-Fu Ho
Journal:  J Mater Sci Mater Med       Date:  2008-10-14       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.